JeanMarie Guenot,PhD is a scientist and executive level manager who has spent her career finding ways to save lives. She has over 20 years of experience in the pharmaceutical industry and has specialized in business development, research & development, project management, and raising venture capital.
In 1993 Guenot earned her PhD at the University of California, San Franciso. In order to further advance her career in management she earned an MBA at the University of Pennsylvania – The Wharton School. During her career she spent several years in research and development in order to develop new life-saving pharmaceuticals. She has also worked at the executive level as a Vice President of Corporate and Business development for PDL bioPharma. In 2008 she founded her own pharmaceutical company she called Guenot, LLC. At this company Guenot offered her consulting services in areas such as raising venture capital, pharmaceutical research and development, and commercial development. In 2009 she saw an opportunity and founded another company, SKS Ocular, LLC, where she developed new technologies in order to meet what she saw were unmet medical needs in the ocular industry. One of the technologies she developed was a way to insert microparticles into the front and back sides of the eye that sustainably deliver drugs to treat eye disease.
Today JeanMarie Guenot serves as the Chief Executive Officer and President of San Francisco-based Amphivena Therapeutics. This company is focused on developing bi-functional antibody therapy in order to treat blood cancer. In the last few years she has also co-founded Harpoon Therapeutics, Inc., and Maverick Therapeutics. Both companies are privately held companies that are researching cancer cures in the field of biotechnology. Amphivena Therapeutics has been named as one of the 10 hottest Bay Area biotech startups by BioSpace. Biospace credits the company’s work to develop new protein-based therapeutics.